CL2020000293A1 - Gel que comprende clorhexidina. - Google Patents

Gel que comprende clorhexidina.

Info

Publication number: CL2020000293A1
Authority: CL; Chile
Prior art keywords: chlorhexidine; gels; diseases; pharmaceutically acceptable; oral cavity
Prior art date: 2017-08-04

Application number

CL2020000293A

Other languages

English (en)

Spanish (es)

Inventor

Risueño Joaquín Balasch

López Marta Embid

Original Assignee

Laboratorios Kin S A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-08-04

Filing date

2020-01-31

Publication date

2020-08-14

2020-01-31 Application filed by Laboratorios Kin S A filed Critical Laboratorios Kin S A

2020-08-14 Publication of CL2020000293A1 publication Critical patent/CL2020000293A1/es

Links

GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 title abstract 2
229960003260 chlorhexidine Drugs 0.000 title abstract 2
239000000499 gel Substances 0.000 abstract 3
239000011159 matrix material Substances 0.000 abstract 2
210000000214 mouth Anatomy 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
229920002678 cellulose Polymers 0.000 abstract 1
239000001913 cellulose Substances 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
230000006806 disease prevention Effects 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
229920002674 hyaluronan Polymers 0.000 abstract 1
229960003160 hyaluronic acid Drugs 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Birds (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Oral & Maxillofacial Surgery (AREA)
Dermatology (AREA)
Cosmetics (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CL2020000293A 2017-08-04 2020-01-31 Gel que comprende clorhexidina. CL2020000293A1 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP17382547		2017-08-04
IE20170230A IE87094B1 (en)	2017-08-04	2017-11-02	Gel comprising chlorhexidine

Publications (1)

Publication Number	Publication Date
CL2020000293A1 true CL2020000293A1 (es)	2020-08-14

Family

ID=63047391

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL2020000293A CL2020000293A1 (es)	2017-08-04	2020-01-31	Gel que comprende clorhexidina.

Country Status (11)

Country	Link
EP (1)	EP3661480A1 (de)
CN (1)	CN110996891B (de)
BR (1)	BR112020002106B1 (de)
CL (1)	CL2020000293A1 (de)
CR (1)	CR20200058A (de)
IE (1)	IE87094B1 (de)
MX (1)	MX2020001363A (de)
NI (1)	NI202000007A (de)
PE (1)	PE20200698A1 (de)
PH (1)	PH12020550032A1 (de)
WO (1)	WO2019025599A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2022538521A (ja)	2019-06-14	2022-09-05	ザプロクターアンドギャンブルカンパニー	洗い流さない口腔ケア組成物
MX2021015126A (es)	2019-06-14	2022-01-24	Procter & Gamble	Composiciones para el cuidado bucal para usar y no enjuagar.
WO2020248232A1 (en) *	2019-06-14	2020-12-17	The Procter & Gamble Company	Leave-on oral care compositions
WO2020248239A1 (en)	2019-06-14	2020-12-17	The Procter & Gamble Company	Leave-on oral care compositions
EP3982917A1 (de)	2019-06-14	2022-04-20	The Procter & Gamble Company	Verweil-mundpflegezusammensetzungen
CN111494376A (zh) *	2020-06-15	2020-08-07	牡丹江医学院	一种用于治疗牙龈炎的药物及其制备方法
IT202000029288A1 (it) *	2020-12-01	2022-06-01	Altergon Sa	Sali di microbiocidi biguanidinici con glicosamminoglicani
CA3218883A1 (en) *	2021-05-26	2022-12-01	Murilo Nogueira NAKAJIMA	Oral care compositions
CN113440441B (zh) *	2021-07-29	2022-09-16	山东福瑞达生物股份有限公司	一种含精油的口腔抑菌组合物及其制备方法
EP4483889A1 (de)	2023-06-28	2025-01-01	Igen Biolab Group AG	Postbiotische zusammensetzung zur oralen verabreichung zur vorbeugung oder behandlung von munddysbiose
GR1010853B (el) *	2023-11-10	2025-01-10	Ιουλια Τσετη	Συνθεση υαλουρονικου νατριου και σουκραλφατης καταλληλη για χορηγηση στη στοματικη κοιλοτητα
CN119033680A (zh) *	2024-08-28	2024-11-29	西南医科大学附属口腔医院	一种用于口腔黏膜损伤的水凝胶的制备方法及应用
CN120309762B (zh) *	2025-04-29	2026-01-06	杭州三言生物科技有限公司	一种具有抑菌作用的透明质酸氯己定的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5192802A (en)	1991-09-25	1993-03-09	Mcneil-Ppc, Inc.	Bioadhesive pharmaceutical carrier
CH691030A5 (it)	1995-09-26	2001-04-12	Apr Applied Pharma Res Sa	Formulazioni per uso topico contenenti carragenina ed un sale dell'acido ialuronico.
JPH1160505A (ja)	1997-05-20	1999-03-02	Senju Pharmaceut Co Ltd	防腐組成物
US6117415A (en)	1999-06-17	2000-09-12	Alpharx Inc.	Toothpaste comprising bioadhesive submicron emulsion for improved delivery of antibacterial and anticaries agents
US8283135B2 (en) *	2000-06-30	2012-10-09	The Procter & Gamble Company	Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
RU2286764C1 (ru)	2005-06-16	2006-11-10	Георгий Георгиевич Ростиашвили	Средство "гиалудент" пролонгированного действия для лечения воспалительных заболеваний полости рта
US8609634B2 (en)	2007-05-16	2013-12-17	Mcneil-Ppc, Inc.	Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
US20090068122A1 (en) *	2007-09-06	2009-03-12	Shira Pilch	Dentifrice Compositions for Treating Xerostomia
EP2520279A1 (de) *	2011-05-02	2012-11-07	TERES S.r.l.	Thermoreversible pharmazeutische Gelzusammensetzungen zur zahnmedizinischen Verwendung
CN104474582A (zh) *	2014-12-17	2015-04-01	安徽省健源医疗器械设备有限公司	一种含透明质酸的止血纱布及其制备方法
PL3171854T3 (pl) *	2015-05-08	2020-11-02	Curasept Ads S.R.L.	Ulepszony preparat płynu do płukania jamy ustnej
CN105342939A (zh) *	2015-12-15	2016-02-24	山东消博士消毒科技股份有限公司	可降低手术切口感染的消毒沐浴液及其制备工艺
CN106540281A (zh) *	2016-12-08	2017-03-29	邓丽萍	B超耦合剂及其制备工艺

2017
- 2017-11-02 IE IE20170230A patent/IE87094B1/en unknown
2018
- 2018-08-03 PE PE2020000181A patent/PE20200698A1/es unknown
- 2018-08-03 BR BR112020002106-7A patent/BR112020002106B1/pt active IP Right Grant
- 2018-08-03 MX MX2020001363A patent/MX2020001363A/es unknown
- 2018-08-03 CN CN201880052414.5A patent/CN110996891B/zh active Active
- 2018-08-03 EP EP18746958.0A patent/EP3661480A1/de active Pending
- 2018-08-03 CR CR20200058A patent/CR20200058A/es unknown
- 2018-08-03 WO PCT/EP2018/071155 patent/WO2019025599A1/en not_active Ceased
2020
- 2020-01-21 PH PH12020550032A patent/PH12020550032A1/en unknown
- 2020-01-28 NI NI202000007A patent/NI202000007A/es unknown
- 2020-01-31 CL CL2020000293A patent/CL2020000293A1/es unknown

Also Published As

Publication number	Publication date
EP3661480A1 (de)	2020-06-10
WO2019025599A1 (en)	2019-02-07
PE20200698A1 (es)	2020-06-16
CR20200058A (es)	2020-03-28
CN110996891B (zh)	2023-02-28
BR112020002106A8 (pt)	2020-12-01
NI202000007A (es)	2020-07-31
PH12020550032A1 (en)	2021-02-15
BR112020002106A2 (pt)	2020-08-04
IE87094B1 (en)	2020-05-13
MX2020001363A (es)	2020-03-20
CN110996891A (zh)	2020-04-10
IE20170230A1 (en)	2019-02-06
BR112020002106B1 (pt)	2023-04-18

Publication	Publication Date	Title
CL2020000293A1 (es)	2020-08-14	Gel que comprende clorhexidina.
CO2020000145A2 (es)	2020-01-17	Carboxamidas como moduladores de los canales de sodio
CL2020002698A1 (es)	2021-01-15	Moduladores de enzimas modificadoras de metilo, composiciones y usos de estos
CO2021005070A2 (es)	2021-04-30	Inhibición de la proteasa 30 específica de la ubiquitina (usp30)
CL2020002562A1 (es)	2021-01-15	(divisional de solicitud 1097-2020) derivados de piridincarbonilo y usos terapéuticos de los mismos como inhibidores de trpc6.
MX387604B (es)	2025-03-18	Formulaciones cannabinoides estables.
UY31068A1 (es)	2009-01-05	Ligandos purinoreceptores p2x, metodos para la prparacion de los mismos, composiciones farmaceuticas que los contienen y sus usos 570
CO6430456A2 (es)	2012-04-30	Derivados de aminotetralina, composiciones farmaceuticas que los contienen y sus usos en terapia
CO2020000240A2 (es)	2020-04-24	Combinación que comprende palbociclib y ácido 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxílico
MX2019001877A (es)	2019-09-13	Composiciones farmaceuticas oftalmicas y usos que se relacionan a las mismas.
PE20170302A1 (es)	2017-03-31	Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington
AR052854A1 (es)	2007-04-04	Metodo para reducir la inflamacion del tejido oral utilizando extracto de magnolia
UY31294A1 (es)	2009-03-31	Derivados de tetrahidrocarbozol, métodos para obtenerlos, formulaciones que los contienen y usos de los mismos
ES2187300B1 (es)	2004-06-16	Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
UY31334A1 (es)	2009-04-30	3a,4,5,6,7,7a-hexahidro-3h-benzoimidazol y derivaods de 3a, 4,5,6,,7,7a-hexahidro-3-indol, enantiómeros, diastereoisómeros, sales farmacéuticamente aceptadas, mezclas, composiciones, preparaciones y aplicaciones de las mismas
AR069508A1 (es)	2010-01-27	Derivados de quinolina 057; un proceso para su preparacion; una composicion farmaceutica; la preparacion de esta y el uso del compuesto para preparar un medicamento
CY1122387T1 (el)	2020-11-25	Διπλης χρησης δισκια στοματικης φαρμακευτικης συνθεσης θειικων αλατων και μεθοδοι χρησης αυτων
MX2017012942A (es)	2018-01-30	Formulaciones farmaceuticas.
AR120320A1 (es)	2022-02-09	Composiciones estéticas listas para usar
AR088845A1 (es)	2014-07-10	Composiciones farmaceuticas que contienen 7-(1h-imidazol-4-ilmetil)-5,6,7,8-tetrahidro-quinolina para el tratamiento de las enfermedades y las afecciones de la piel
UY28715A1 (es)	2005-08-31	Derivados de diarilmetil piperazina, sus preparaciones y sus usos
DOP2017000138A (es)	2017-07-31	Derivados de fumagilol
MX2021001488A (es)	2021-04-28	Composiciones blanqueadoras y metodos para las mismas.
CU24444B1 (es)	2019-10-04	Formulaciones tópicas de heparina
ES2157644T3 (es)	2001-08-16	Nuevos derivados aminados del 6,7,8,9-tetrahidro-ciclopenta-(a)-naftaleno y del 2,3-dihidro-ciclopenta-(e)-indeno, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.